Puma Biotechnology reported $48.34M in Operating Expenses for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amgen AMGN:US $ 3.74B 804M
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Cerulean Pharma CERU:US $ 9.54M 3.13M
Clovis Oncology CLVS:US $ 84.61M 6.4M
Daiichi Sankyo 4568:JP 284.67B 42.7B
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Gilead Sciences GILD:US $ 6393M 89M
Glaxosmithkline GSK:US 6.98B 1.65B
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Moderna Inc MRNA:US 1.84B 38M
Novartis NOVN:VX 9.96B 998M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Spectrum Pharmaceuticals SPPI:US $ 14.06M 22.79M
Takeda 4502:JP 874.91B 90.1B
Tg Therapeutics TGTX:US $ 68.89M 26.38M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vanda Pharmaceuticals VNDA:US $ 67.86M 8.48M
YTE INCY:US $ 616.69M 135.42M